Glass Investments

Glass Investments is a private investment firm based in Guernsey that focuses on opportunistic investments in emerging technologies, including the life sciences and biotechnology sectors. The firm is notably recognized for its historical involvement as a significant shareholder in Biomedical Detection Inc. (BDI), a life science tools company specializing in label-free, real-time detection of bio-molecular interactions for drug discovery. Glass Investments provides capital and strategic oversight to its portfolio companies, often participating in late-stage venture and private equity financings. Led by President Marc Sontrop, the firm manages a diverse portfolio that bridges the gap between innovative scientific research and commercial application.